ClinVar Miner

Submissions for variant NM_032043.3(BRIP1):c.1226G>T (p.Ser409Ile)

dbSNP: rs587782247
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000130955 SCV000185870 uncertain significance Hereditary cancer-predisposing syndrome 2013-12-16 criteria provided, single submitter clinical testing The p.S409I variant (also known as c.1226G>T), located in coding exon 8 of the BRIP1 gene, results from a G to T substitution at nucleotide position 1226. The serine at codon 409 is replaced by isoleucine, an amino acid with dissimilar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. To date, this alteration has been detected with an allele frequency of approximately 0.01% (greater than 9500 alleles tested) in our clinical cohort (includes this individual).This amino acid position is well conserved through reptiles on sequence alignment.In addition, this alteration is predicted to be possibly damaging and deleterious by PolyPhen and SIFT in silico analyses, respectively.Since supporting evidence is limited at this time, the clinical significance of p.S409I remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.